Sixian Chu

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.

G. Suck, S. Chu, M. Niam, 2011, Experimental hematology.

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.

G. Suck, S. Chu, M. Niam, 2011, Experimental hematology.

KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesiveness.

A. Vararattanavech, Suet-Mien Tan, G. Suck, 2011, Frontiers in bioscience.

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

W. Hwang, G. Suck, S. Chu, 2012, Bone Marrow Transplantation.